PERIOPERATIVE AND POSTOPERATIVE CHANGES IN SERUM LEVELS OF 4 TUMOR-MARKERS AND 3 ACUTE PHASE REACTANTS IN BENIGN AND MALIGNANT GYNECOLOGICAL DISEASES

被引:7
作者
AVALLLUNDQVIST, E
SJOVALL, K
HANSSON, LO
ENEROTH, P
机构
[1] HUDDINGE HOSP,CLIN RES CTR,APPL BIOCHEM UNIT,S-10401 STOCKHOLM,SWEDEN
[2] KAROLINSKA HOSP,DEPT CLIN CHEM,S-10401 STOCKHOLM 60,SWEDEN
关键词
SURGICAL TRAUMA; TUMOR MARKERS; ACUTE PHASE REACTANTS; GYNECOLOGICAL DISEASE;
D O I
10.1007/BF02759914
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Serum levels of squamous cell carcinoma antigen, carcinoembryonic antigen, CA 125, tissue polypeptide antigen, CRP, alpha(1)-antitraypsin and haptoglobin were determined peri- and postoperatively in patients undergoing surgery for benign gynecological disease (n = 18) and postoperatively in women operated for cervical carcinoma (n = 23). The only significant changes seen after premedication, during anesthesia and during surgery were a decrease in serum concentrations of alpha(1)-antitrypsin and haptoglobin. We found no postoperative changes in the serum levels of squamous cell carcinoma antigen nor in carcinoembryonic antigen values. However, the latter analyte was influenced by smoking habits. Elevated levels of CA 125 and tissue polypeptide antigen were found in the cancer patients, predominantly within the first 1-3 weeks after surgery. These levels decreased to normal values within 4-6 weeks postoperatively. The median intraindividual coefficients of variation for the tumor markers ranged between 15% and 28% in 30 control women not having surgery. In general, it would seem advisable to wait 6 weeks after surgery before monitoring with CA 125 and TPA is started.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 27 条
[1]  
Avall Lundqvist E, 1991, Eur J Gynaecol Oncol, V12, P375
[2]  
BAUMANN H, 1990, MOL BIOL MED, V7, P147
[3]  
BJORKLUND B, 1983, PROTIDES BIOL FLUIDS, V31, P425
[4]   MATERNAL AND CORD SERUM LEVELS OF TISSUE POLYPEPTIDE ANTIGEN (TPA) IN NORMAL PREGNANCIES [J].
BREMME, K ;
ENEROTH, P ;
NILSSON, B ;
OLSSON, M .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1985, 19 (03) :118-123
[5]   OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER [J].
CANNEY, PA ;
MOORE, M ;
WILKINSON, PM ;
JAMES, RD .
BRITISH JOURNAL OF CANCER, 1984, 50 (06) :765-769
[6]   SERUM CA-125 LEVELS IN PATIENTS WITH A PROVISIONAL DIAGNOSIS OF PELVIC INFLAMMATORY DISEASE - CLINICAL AND THEORETICAL IMPLICATIONS [J].
DUK, JM ;
KAUER, FM ;
FLEUREN, GJ ;
DEBRUIJN, HWA .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1989, 68 (07) :637-641
[7]  
FIORE M, 1988, CLIN CHEM, V34, P1726
[8]  
Fleck A, 1985, ACUTE PHASE RESPONSE, P249
[9]  
FLEUREN GJ, 1987, CANCER, V60, P2437, DOI 10.1002/1097-0142(19871115)60:10<2437::AID-CNCR2820601015>3.0.CO
[10]  
2-K